Pfizer Inc (PFE)

$28.08 +0.31 (1.12%)
Market Cap 157.91B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.37
Forward PE 9.10
Profit Margin 12.42%
Debt to Equity Ratio 0.75
Volume 44,841,500
Avg Vol 45,483,211
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 88%
Beta 0.47
Analysts Sell
Price Target $28.98

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
DragonAlgo
DragonAlgo Apr. 1 at 3:55 AM
🐉 $PFE CALL — DragonAlgo® Signal Contract: PFE CALL Expiry: 2026-04-02 | Strike: $28.00 | Type: CALL Option Plan (premium): Entry: $0.30 Stop: $0.22 TP1: $0.40 TP2: $0.52 TP3: $0.73 🔗 https://dragonalgo.com
0 · Reply
TwelveEggsInOneBasket
TwelveEggsInOneBasket Apr. 1 at 3:45 AM
$PFE well over due for its upswing. If the market hit bottem, this will follow up to $40 on the next market leg up as focus falls off of tech and moves down stream into companies benefiting from all this AI and automation.
0 · Reply
WaverVanir
WaverVanir Apr. 1 at 2:24 AM
$PFE
0 · Reply
stockjusthave
stockjusthave Apr. 1 at 1:26 AM
$NVAX $PFE looks like two birds go together
0 · Reply
JBS_84
JBS_84 Mar. 31 at 11:51 PM
$PFE I meant 28.3
0 · Reply
stockjusthave
stockjusthave Mar. 31 at 11:50 PM
$PFE this one cannot have volatile move even when supposed to be turmoil end. soon some negative news for this one because Cramer said pass so fail.
1 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Mar. 31 at 11:17 PM
$PFE $30 next Nice tight ascending triangle 5 year chart
0 · Reply
JBS_84
JBS_84 Mar. 31 at 10:22 PM
$PFE Add 1 to each of those and i would agree!
0 · Reply
JBS_84
JBS_84 Mar. 31 at 10:15 PM
$PFE Thats fine, as long as it holds tomorrow morning we should retest 27.3. It could break or come back to support at that point.
2 · Reply
Nosh
Nosh Mar. 31 at 10:09 PM
$PFE Interesting...
0 · Reply
Latest News on PFE
Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.

Mar 30, 2026, 10:44 AM EDT - 1 day ago

Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.

GSK LLY NVO PPH

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

Mar 24, 2026, 10:00 AM EDT - 7 days ago

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

Mar 23, 2026, 12:46 PM EDT - 8 days ago

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

VALN

Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive

Mar 23, 2026, 10:35 AM EDT - 8 days ago

Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive

VALN

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

Mar 23, 2026, 9:36 AM EDT - 8 days ago

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

VALN

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Mar 23, 2026, 7:07 AM EDT - 8 days ago

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

VALN

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

Mar 23, 2026, 7:02 AM EDT - 8 days ago

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

VALN

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

Mar 23, 2026, 6:47 AM EDT - 8 days ago

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

VALN

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

Mar 23, 2026, 6:45 AM EDT - 8 days ago

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

VALN

5 ‘Healthy' Dividends Paying Up To 14.1%

Mar 22, 2026, 9:45 AM EDT - 9 days ago

5 ‘Healthy' Dividends Paying Up To 14.1%

ARE BME DOC HQH

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

Mar 20, 2026, 4:30 PM EDT - 11 days ago

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

Mar 19, 2026, 6:45 AM EDT - 12 days ago

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

TrumpRx lists many medicines at prices higher than paid in UK

Mar 18, 2026, 2:23 PM EDT - 13 days ago

TrumpRx lists many medicines at prices higher than paid in UK

ABBV AMGN AZN BMY GILD GSK JNJ

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Mar 17, 2026, 7:49 AM EDT - 14 days ago

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Mar 17, 2026, 6:45 AM EDT - 14 days ago

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Mar 9, 2026, 7:27 AM EDT - 22 days ago

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

Mar 9, 2026, 6:45 AM EDT - 22 days ago

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

China approves Pfizer GLP-1 drug for weight management

Mar 6, 2026, 12:40 AM EST - 25 days ago

China approves Pfizer GLP-1 drug for weight management

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

Mar 5, 2026, 4:48 PM EST - 26 days ago

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

Mar 4, 2026, 8:55 AM EST - 27 days ago

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

SMWB

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields

Mar 3, 2026, 8:10 AM EST - 4 weeks ago

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields

PRGO XRAY

Pfizer CEO flags issues with FDA's vaccine leadership

Mar 2, 2026, 11:14 AM EST - 4 weeks ago

Pfizer CEO flags issues with FDA's vaccine leadership

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

Feb 27, 2026, 10:00 AM EST - 4 weeks ago

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Feb 24, 2026, 2:29 PM EST - 5 weeks ago

U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Feb 24, 2026, 7:45 AM EST - 5 weeks ago

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Pfizer in diabetes drug deal with Sciwind Biosciences

Feb 23, 2026, 10:26 PM EST - 5 weeks ago

Pfizer in diabetes drug deal with Sciwind Biosciences

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

Feb 23, 2026, 3:15 PM EST - 5 weeks ago

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

MRK MRNA

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Feb 23, 2026, 10:00 AM EST - 5 weeks ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Is There 25% Downside For Pfizer Stock?

Feb 18, 2026, 12:00 PM EST - 5 weeks ago

Is There 25% Downside For Pfizer Stock?

Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Feb 17, 2026, 6:45 AM EST - 6 weeks ago

Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Prices, pipelines and patent cliffs: Inside pharma's big reset

Feb 13, 2026, 6:13 AM EST - 6 weeks ago

Prices, pipelines and patent cliffs: Inside pharma's big reset

AMGN LLY NVO

These 32 favorite stocks signal the bull market is running on fumes

Feb 12, 2026, 8:05 AM EST - 6 weeks ago

These 32 favorite stocks signal the bull market is running on fumes

AAPL ABT ADBE AMGN AVGO BAC BK

Is Pfizer Stock Now A Value Trap?

Feb 11, 2026, 8:56 AM EST - 6 weeks ago

Is Pfizer Stock Now A Value Trap?

Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund

Feb 10, 2026, 3:20 PM EST - 7 weeks ago

Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund

Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

Feb 6, 2026, 2:55 PM EST - 7 weeks ago

Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

Feb 6, 2026, 6:45 AM EST - 7 weeks ago

FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

Feb 5, 2026, 7:09 PM EST - 7 weeks ago

Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

Obesity stocks slump on Novo's underwhelming 2026 sales forecast

Feb 3, 2026, 1:27 PM EST - 2 months ago

Obesity stocks slump on Novo's underwhelming 2026 sales forecast

ALT AMGN GPCR LLY NVO VKTX

Silver Surges Over 15%; Pfizer Earnings Top Views

Feb 3, 2026, 12:00 PM EST - 2 months ago

Silver Surges Over 15%; Pfizer Earnings Top Views

Pfizer, Merck report Q4 results: Citi's Geoff Meacham on key takeaways

Feb 3, 2026, 11:17 AM EST - 2 months ago

Pfizer, Merck report Q4 results: Citi's Geoff Meacham on key takeaways

MRK

Pfizer beats quarterly estimates despite Covid product decline - reaffirms modest outlook

Feb 3, 2026, 10:15 AM EST - 2 months ago

Pfizer beats quarterly estimates despite Covid product decline - reaffirms modest outlook

Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops

Feb 3, 2026, 8:50 AM EST - 2 months ago

Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops

Pfizer maps post-Covid reset with obesity trials and deep cost cuts

Feb 3, 2026, 8:17 AM EST - 2 months ago

Pfizer maps post-Covid reset with obesity trials and deep cost cuts

Pfizer says once-a-month weight-loss drug works as it forecasts profit decline

Feb 3, 2026, 7:28 AM EST - 2 months ago

Pfizer says once-a-month weight-loss drug works as it forecasts profit decline

Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand

Feb 3, 2026, 7:21 AM EST - 2 months ago

Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand

Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial

Feb 3, 2026, 7:18 AM EST - 2 months ago

Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street.

Feb 3, 2026, 7:02 AM EST - 2 months ago

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street.

Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook

Feb 3, 2026, 6:57 AM EST - 2 months ago

Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook

Pfizer beats fourth-quarter profit estimates on strong drug demand

Feb 3, 2026, 6:50 AM EST - 2 months ago

Pfizer beats fourth-quarter profit estimates on strong drug demand

Pfizer's experimental drug shows up to 12.3% weight loss in mid-stage trial

Feb 3, 2026, 6:45 AM EST - 2 months ago

Pfizer's experimental drug shows up to 12.3% weight loss in mid-stage trial

DragonAlgo
DragonAlgo Apr. 1 at 3:55 AM
🐉 $PFE CALL — DragonAlgo® Signal Contract: PFE CALL Expiry: 2026-04-02 | Strike: $28.00 | Type: CALL Option Plan (premium): Entry: $0.30 Stop: $0.22 TP1: $0.40 TP2: $0.52 TP3: $0.73 🔗 https://dragonalgo.com
0 · Reply
TwelveEggsInOneBasket
TwelveEggsInOneBasket Apr. 1 at 3:45 AM
$PFE well over due for its upswing. If the market hit bottem, this will follow up to $40 on the next market leg up as focus falls off of tech and moves down stream into companies benefiting from all this AI and automation.
0 · Reply
WaverVanir
WaverVanir Apr. 1 at 2:24 AM
$PFE
0 · Reply
stockjusthave
stockjusthave Apr. 1 at 1:26 AM
$NVAX $PFE looks like two birds go together
0 · Reply
JBS_84
JBS_84 Mar. 31 at 11:51 PM
$PFE I meant 28.3
0 · Reply
stockjusthave
stockjusthave Mar. 31 at 11:50 PM
$PFE this one cannot have volatile move even when supposed to be turmoil end. soon some negative news for this one because Cramer said pass so fail.
1 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Mar. 31 at 11:17 PM
$PFE $30 next Nice tight ascending triangle 5 year chart
0 · Reply
JBS_84
JBS_84 Mar. 31 at 10:22 PM
$PFE Add 1 to each of those and i would agree!
0 · Reply
JBS_84
JBS_84 Mar. 31 at 10:15 PM
$PFE Thats fine, as long as it holds tomorrow morning we should retest 27.3. It could break or come back to support at that point.
2 · Reply
Nosh
Nosh Mar. 31 at 10:09 PM
$PFE Interesting...
0 · Reply
Willieberich
Willieberich Mar. 31 at 8:53 PM
$PFE 27 now is great support .26.50 is next .but this is building great structure..
0 · Reply
Willieberich
Willieberich Mar. 31 at 8:51 PM
$PFE very nice close! Still needs to go to 28.20 or so .then come back to retest 28 .to start creating support at 28 .very nice tho .
0 · Reply
RunnerSignals
RunnerSignals Mar. 31 at 8:36 PM
52 week highs breakout stocks ​$APLS $CNTA $UNIT $BTE $PFE breakouts show selective accumulation RSI elevated yet volume confirms institutions adding not distributing
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Mar. 31 at 8:13 PM
$PFE Comical how there trying to bring this to $28 AH lol
0 · Reply
JBS_84
JBS_84 Mar. 31 at 8:06 PM
$PFE Looks ok, should be good to go. Wider market doesn't really matter much.
0 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 31 at 8:03 PM
$PFE holy shit we closed over 28
0 · Reply
Typecheck
Typecheck Mar. 31 at 8:03 PM
$PFE End of Q1. The banks really want to have a good looking quarter by putting lip stick on a pig.
1 · Reply
JBS_84
JBS_84 Mar. 31 at 7:42 PM
$PFE Stupid 28.03 pivot. If we get past it it will really go
0 · Reply
TycoonYanky
TycoonYanky Mar. 31 at 7:39 PM
$PFE whole market is pumped and this shit is almost flat.. 💩
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Mar. 31 at 6:51 PM
$PFE Get this 🐷 oinking
1 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 31 at 6:44 PM
$PFE pinned
1 · Reply
morgangj
morgangj Mar. 31 at 6:27 PM
$PFE UNDERVALUED. $40.00.
1 · Reply